Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2000 January-February;52(1-2) > Minerva Ginecologica 2000 January-February;52(1-2):25-8

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

CASE REPORT  


Minerva Ginecologica 2000 January-February;52(1-2):25-8

language: Italian

Maternal hyperthyroidism treatment and fetal goitre

Bellini P., Marinetti E., Arreghini A., Andreotti C., Kirm V., Roncaglia N.


PDF  


A fetal goitre is a potentially dangerous phenomenon because of mechanical obstruction and possible fetal thyroid function disorders. During pregnancy women with a history of Graves' disease under treatment with propyl-thiouracil (PTU) have an increased risk for fetal goitre. In this report a patient with Graves' disease diagnosed in early pregnancy and treated with PTU which resulted in a fetal goitre is described. The fetal thyroid status, investigated by percutaneous fetal umbilical cord blood sampling, was normal and the reduction of PTU dosage was sufficient to decrease goitre volume.

top of page

Publication History

Cite this article as

Corresponding author e-mail